Video update with Dr. Daniel Koller

Large cap biotech stocks performed much better than small and mid caps last year. Will this development continue or is a change in sight? Will M&A activity increase again this year and which indications and technologies will be in particular focus? These and other questions are explored in the video update with Dr. Daniel Koller, Head of the Investment Management Team.